SOC Telemed, Inc. TLMD
3.00 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
2.99 Day range 3.00
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 3.00
Ratings (-1m) 6 1 buy · 5 hold · 0 sell
- Strong buy1
- Buy0
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.14 | -0.14 – -0.14 | -0.17 | +17.6% | 26.69M | +80.1% | 1 |
| Next quarter | -0.14 | -0.14 – -0.14 | -0.16 | +12.5% | 27.17M | +7.9% | 1 |
| Current year | -0.57 | -0.57 – -0.57 | -0.55 | -3.6% | 114.04M | +20.8% | 1 |
| Next year | -0.43 | -0.43 – -0.43 | -0.57 | +24.6% | 139.96M | +22.7% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 7, 2022 | Credit Suisse | Maintained | — | Neutral |
| Feb 4, 2022 | Benchmark | Downgrade | Buy | Hold |
| Feb 3, 2022 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Feb 3, 2022 | Baird | Downgrade | Outperform | Neutral |
| Jan 7, 2022 | Credit Suisse | Downgrade | Outperform | Neutral |
| Aug 13, 2021 | RBC Capital | Maintained | — | Outperform |
| Aug 13, 2021 | Credit Suisse | Maintained | — | Outperform |
| May 28, 2021 | Baird | Initiated | — | Outperform |
| Feb 16, 2021 | Credit Suisse | Initiated | — | Outperform |
| Jan 28, 2021 | RBC Capital | Initiated | — | Outperform |
| Jan 15, 2021 | BTIG | Downgrade | Buy | Neutral |
| Jan 15, 2021 | Benchmark | Initiated | — | Buy |
| Jan 7, 2021 | BTIG | Initiated | — | Buy |
| Dec 1, 2020 | Baird | Initiated | — | Outperform |
| Nov 25, 2020 | William Blair | Initiated | — | Outperform |